The aim of this randomized clinical trial is to evaluate the effectiveness of app-delivered cognitive-behavioral therapy for insomnia adjunct to inpatient multimodal rehabilitation for individuals with comorbid insomnia and chronic pain, compared with rehabilitation (usual care) only.
Insomnia is highly prevalent among patients receiving treatment for long-term musculoskeletal complains. Cognitive-behavioral therapy for insomnia (CBT-I) may be effective for improving sleep quality and pain-related outcomes in these patients, but the availability of this therapy is limited by few trained therapists. In this randomized clinical trial we will evaluate the effectiveness of app-delivered CBT-I adjunct to inpatients multimodal rehabilitation for individuals with comorbid insomnia and chronic pain, compared with rehabilitation (usual care) only. Patients referred to Unicare Helsefort (Norway) with long-term chronic musculoskeletal complains and insomnia are invited to the study. The rehabilitation program consists of 2+2 weeks of inpatient multimodal rehabilitation, where the patients are at home for two weeks between the rehabilitation stays. Participants in the intervention group will receive the (CBT-I) while participating in rehabilitation, while the control group will receive rehabilitation without the app (usual care). Based on sample size calculation recruiting 15 clusters with 2:1 randomization will achieve 80 % power to detect a 4-point difference between the intervention and usual treatment group on the insomnia severity index (ISI). Edit 25.08.23: We noted in the review process of a protocol paper that the description of our sample size calculation implied that 150 participants would be included in the study, rather than that 150 potential participants would be screened and that we anticipated that 5 from each group of the 15 clusters would be eligible (i.e. 75 included in the study). We have also revisited the sample size calculations to account for dropouts and low adherence rates known to be a problem in digital interventions. We expect a dropout rate of approximately 20 % and that around 50 % of the participants in the intervention group will complete at least four of the dCBT-I modules. Given that the per-protocol analysis is of particular interest in this study, we aim to recruit 21 clusters to account for the fact that we expect an average of four participants per cluster in the control group to complete the follow-up, and an average of two participants in the intervention group to complete at least four of the modules and attend the follow-up. As total sample size is hard to predict and the sample size is based on number of clusters we have not changed the total enrollment number.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
105
6 week sleep intervention delivered via a smartphone app while taking part in inpatient multimodal rehabilitation for chronic pain lasting 2+2 weeks.
Inpatient multimodal rehabilitation for chronic pain lasting 2+2 weeks.
Unicare Helsefort
Rissa, Hasselvika, Norway
Insomnia
Degree of sleep problems measured by the insomnia severity index (ISI).
Time frame: 3 months of follow-up
Insomnia
Difference in the proportion of participants that achieves an 8-point improvement in their Insomnia Severity Index -score between inpatient multidisciplinary rehabilitation + dCBT-I (intervention group) and inpatient multidisciplinary rehabilitation only (control group).
Time frame: Measured at 3, 6 and 12 months of follow-up, main assessment at 3 months
Insomnia
Degree of sleep problems measured by the insomnia severity index (ISI).
Time frame: 6 and 12 months of follow-up
Health-related quality of life
Measured by the EuroQol EQ5D-5L questionnaire
Time frame: 3, 6 and 12 months of follow-up, main assessment at 3 months
Pain intensity
Scored from 0-100 on a visual analogue scale
Time frame: 3, 6 and 12 months of follow-up, main assessment at 3 months
Sick leave
Registry data from the National Insurance Administration (NAV).
Time frame: 12 months of follow-up
Use of sleep and pain medications
Data from the national prescription registry
Time frame: 12 months of follow-up
Physical function
Measured by the Patient-Specific Functional Scale (PSFS). Scored 0-10.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3, 6 and 12 months of follow-up, main assessment at 3 months
Fatigue
Scored from 0-100 on a visual analogue scale
Time frame: 3, 6 and 12 months of follow-up, main assessment at 3 months
Physical activity
Physical activity measured by a questionnaire adapted from the Trøndelag Health Study (HUNT Study) which consists of three questions about frequency, duration and intensity of physical activity per week.
Time frame: Measured at 3, 6 and 12 months of follow-up, main assessment at 3 months